Kung S

Departments of Psychiatry and Psychology.

14 papers

ArticleKetamine

Hepatic Safety of Ketamine and Esketamine for Treatment-Resistant Depression: A Real-World Cohort Study.

Singh B, Leung JG, Pazdernik VK +2

ArticleKetamine

Early suicidal ideation change and suicidality-associated emergency department utilization after ketamine or esketamine treatment in treatment-resistant depression.

Patarroyo-Rodriguez L, Pazdernik VK, Vande Voort JL +2

ArticleKetamine

Next-Step Treatment Options for Treatment-Resistant Depression: Insights From the Mayo Clinic Depression Center Panel.

Marques MG, Özerdem A, Kung S +10

ArticleKetamine

Intravenous ketamine versus esketamine for depression: a systematic review and meta-analysis.

Elmosalamy A, Tarikogullari I, Patarroyo-Rodriguez L +5

ArticleKetamine

Ketamine Reduces Suicidality-Associated Emergency Department Utilization in Patients With Treatment-Resistant Depression: A 6-Month Mirror-Image Study.

Patarroyo-Rodriguez L, Pazdernik VK, Vande Voort JL +3

ArticleKetamine

Long-Term Outcomes in Patients With Treatment-Refractory Depression Receiving Intravenous Ketamine and Intranasal Esketamine: An Observational Study.

Singh B, Pazdernik VK, Kung S +1

ArticleKetamine

Baseline perceived stress as a predictor of ketamine/esketamine treatment response in treatment-resistant depression.

Cavalcanti S, Pazdernik VK, Vande Voort JL +2

ArticlePsilocybin

Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.

Lapid MI, Pagali SR, Randall AL +13

ArticleKetamine

Intravenous (IV) ketamine versus intranasal esketamine for depression- Advantage IV ketamine?

Singh B, Kung S, Vande Voort JL

ArticleKetamine

A First Trimester Exposure to Ketamine and Esketamine for Depression: A Case Report.

Kummerlowe MN, Kung S, Moore KM +1

ArticleKetamine

Treatment-resistant depression patients with baseline suicidal ideation required more treatments to achieve therapeutic response with ketamine/esketamine.

Singh B, Vande Voort JL, Pazdernik VK +2

ArticleKetamine

Hypersomnia as a predictor of response to intravenous ketamine/intranasal esketamine in treatment resistant depression.

Patarroyo-Rodriguez L, Pazdernik V, Vande Voort JL +2

ArticleKetamine

Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report.

Joseph B, Nunez NA, Kung S +11

ArticleKetamine

Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression: An Observational Study.

Singh B, Kung S, Pazdernik V +5